TOWA (6315) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Driven primarily by a recovery in demand for the Semiconductor Manufacturing Equipment Business, the Company achieved a substantial increase in revenue and profit, reversing the operating loss recorded in the same period of the previous year, with profitability entering a normalization trajectory. Revenue was ¥16.18B (¥8.08B in the previous year, YoY +100.3%), Operating Income was ¥2.21B (an operating loss of ¥0.58B in the previous year), Ordinary Income was ¥2.33B (an ordinary loss of ¥0.73B in the previous year), and Net Income was ¥1.66B (a net loss of ¥0.53B in the previous year). The Operating Income margin was 13.7%, a significant improvement from -7.2% in the same period of the previous year. The primary driver of the revenue increase was progress in working through orders in the Semiconductor Manufacturing Equipment Business, while the primary drivers of the profit increase were improved gross margin accompanying the recovery in operating rates and the restraint of SG&A expenses relative to revenue.

Factors Driving Earnings Changes

【Revenue】Revenue of ¥16.18B (YoY +100.3%) was driven by a sharp recovery in the core Semiconductor Manufacturing Equipment Business. Revenue in this business was ¥15.13B (+110.1%), accounting for 93.5% of total revenue. The Medical Device Business generated revenue of ¥0.68B (+14.5%), while the Laser Processing Equipment Business generated revenue of ¥0.37B (+30.3%), with both businesses posting revenue growth. Revenue concentration in the Semiconductor Manufacturing Equipment Business increased further from the previous year.

【Profit and Loss】Cost of sales was limited to ¥10.73B (66.3% of revenue, compared with 73.3% in the previous year), and the gross margin improved to 33.7% from 26.7% in the previous year, an improvement of 7.0pt. SG&A expenses were ¥3.24B (20.0% of revenue, compared with 33.9% in the previous year), remaining relatively restrained against the increase in revenue and leading to a return to positive Operating Income of ¥2.21B. Ordinary Income of ¥2.33B was lifted by the net difference between non-operating income of ¥0.29B, including dividend income of ¥0.07B, and non-operating expenses of ¥0.17B, including interest expenses of ¥0.07B and foreign exchange losses of ¥0.09B. Net Income of ¥1.66B resulted after deducting income taxes and other taxes of ¥0.67B (effective tax rate: 28.9%); the gap from Ordinary Income was attributable to the tax burden, with no particular abnormal factors. Revenue and profit increased.

Segment Analysis

The Semiconductor Manufacturing Equipment Business generated revenue of ¥15.13B (+110.1%, composition ratio: 93.5%) and Operating Income of ¥2.13B, turning profitable from a loss of ¥0.61B in the previous year, with a margin of 14.1%; it drove nearly all of the Company-wide profit. The Medical Device Business generated revenue of ¥0.68B (+14.5%, composition ratio: 4.2%) and Operating Income of ¥0.13B (+29.3%), maintaining the highest profitability among all segments with a margin of 19.5%. The Laser Processing Equipment Business generated revenue of ¥0.37B (+30.3%, composition ratio: 2.3%) and an operating loss of ¥0.047B, narrowing the loss from ¥0.076B in the previous year but not yet turning profitable. The concentration of revenue and profit in the Semiconductor Manufacturing Equipment Business has increased further from the previous year, and the structure in which demand trends in this business determine Company-wide performance remains in place.

Key Financial Metrics

【Profitability】The Operating Income margin was 13.7% (-7.2% in the previous year), while the Net Income margin was 10.2% (-6.5% in the previous year); both improved significantly and turned profitable. ROE was 2.2%, reflecting the sharp recovery in Net Income. 【Cash Flow Quality】Against Ordinary Income of ¥2.33B, Net Income was ¥1.66B; the difference was attributable to income taxes and other taxes of ¥0.67B (effective tax rate: 28.9%), while extraordinary gains and losses were nearly nonexistent. 【Investment Efficiency】Accounts receivable were ¥17.77B (¥16.16B in the previous year, +9.9%), and inventories were ¥6.14B (¥5.68B in the previous year, +8.0%); both were well below the +100.3% increase in revenue, indicating that the increase in working capital during the revenue growth phase was relatively restrained. 【Financial Soundness】Although the Equity Ratio declined slightly to 64.9% from 66.4% in the previous year, it remained high. Short-term liquidity was ample, with a current ratio of 227.1% and a quick ratio of 207.6%. Cash and deposits of ¥29.72B exceeded interest-bearing debt of ¥20.59B, securing net cash of approximately ¥9.13B, while interest coverage was approximately 30.6x, indicating strong debt-servicing capacity.

Cash Flow Analysis

As cash flow statement data has not been disclosed, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥29.72B, up +4.6% from ¥28.43B in the previous year, indicating a steady accumulation of liquidity on hand even as revenue doubled. Meanwhile, short-term borrowings increased to ¥15.00B (¥11.50B in the previous year, +30.4%), suggesting that funding for working capital requirements and growth investments during the revenue growth phase may be reflected in the financing structure. Investment securities increased substantially to ¥13.30B (¥7.55B in the previous year, +76.1%), indicating that a portion of excess funds was allocated to marketable assets. The fact that the growth rates of accounts receivable and inventories were well below the revenue growth rate indicates that the expansion of working capital was restrained relative to business growth, which can be interpreted as a positive change from the perspective of capital efficiency.

Quality of Earnings

Current-period profit was centered on recurring earnings generated by the core business. Extraordinary gains and losses were extremely limited, consisting of extraordinary income of ¥0.001B and extraordinary losses of ¥0.002B, and there was effectively no upward or downward impact from temporary factors. Non-operating income of ¥0.29B (1.8% of revenue) was mainly dividend income of ¥0.07B, while non-operating expenses of ¥0.17B were mainly interest expenses of ¥0.07B and foreign exchange losses of ¥0.09B; the impact of both on earnings was limited. The difference between Ordinary Income of ¥2.33B and Net Income of ¥1.66B was primarily attributable to income taxes and other taxes of ¥0.67B (effective tax rate: 28.9%), which remained at a standard level. On the other hand, comprehensive income was ¥6.41B, substantially exceeding Net Income of ¥1.66B, as valuation differences on available-for-sale securities of +¥3.94B and foreign currency translation adjustments of +¥0.82B boosted OCI. This difference was attributable to market factors, such as an increase in unrealized gains on investment securities, and should be evaluated separately from the recurring earnings power of the core business.

Earnings Forecast and Guidance

Against the full-year Company plan (Revenue of ¥64.00B, Operating Income of ¥10.24B, Ordinary Income of ¥10.24B, Net Income of ¥7.00B, EPS of ¥93.30, and dividend of ¥24.00), progress in Q1 was 25.3% for Revenue and 23.7% for Net Income, representing broadly standard progress based on the guideline of 25% for evenly distributed quarterly progress. Meanwhile, progress was somewhat behind for Operating Income at 21.6% and Ordinary Income at 22.8%; therefore, maintaining operating rates and implementing cost improvements from Q2 onward will be key to achieving the full-year plan. Neither the earnings forecast nor the dividend forecast had been revised as of the current quarter.

Shareholder Returns

The annual dividend forecast remains unchanged at ¥24.00, implying a Payout Ratio of approximately 25.7% based on the full-year Company plan EPS of ¥93.30. With cash and deposits of ¥29.72B against interest-bearing debt of ¥20.59B, the Company has secured net cash of approximately ¥9.13B, and the burden of this dividend level is limited from the perspective of liquidity on hand. Data on share repurchases has not been disclosed.

Risk Factors

1. Business concentration risk: The Semiconductor Manufacturing Equipment Business accounts for 93.5% of Revenue and nearly all of Operating Income, resulting in high earnings sensitivity to order trends and the capital investment cycle in this business.

2. Reliance on short-term funding: Of interest-bearing debt of ¥20.59B, short-term borrowings and long-term borrowings due within one year total approximately ¥17.00B, representing approximately 82.5% of the total. Although cash and deposits of ¥29.72B exceed this amount and refinancing resilience is secured, the Company retains a structure that is susceptible to changes in the interest-rate environment.

3. Foreign exchange risk: The Company recorded a foreign exchange loss of ¥0.09B during the current period, representing part of non-operating expenses of ¥0.17B, indicating that foreign exchange sensitivity arising from overseas transactions can affect earnings.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin exceed the industry median and are close to the upper bound of the IQR.

Growth and Capital Efficiency

The Revenue growth rate substantially exceeds the industry median, and the benefit from the recovery in semiconductor-related demand is particularly pronounced compared with peers.

Source: Compiled by the Company

Key Takeaways from the Financial Results

1. The Company clearly turned profitable from the operating loss, ordinary loss, and net loss recorded in the same period of the previous year, with the Operating Income margin recovering to 13.7%, above the industry median of 8.7%. Normalization of the profit structure has been confirmed.

2. Against revenue growth of +100.3%, the increases in accounts receivable of +9.9% and inventories of +8.0% were relatively restrained, indicating that the deterioration in capital efficiency during the revenue growth phase was limited.

3. While progress toward the full-year plan for Revenue and Net Income was broadly standard, Operating Income progress was somewhat behind at 21.6%; execution of operating-rate maintenance and cost improvements in the second half will be the key determinant of whether the full-year plan is achieved.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥959–¥1,016 at ±1% for the cost of equity, and ¥986–¥987 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest-rate reference month: 2026-07 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

TOWA delivered a strong FY2027 Q1 earnings rebound, led by a sharp recovery in semiconductor manufacturing equipment sales and a return to operating profitability. Revenue doubled year on year to ¥16.18bn, up 100.3% from ¥8.08bn. Operating income improved to ¥2.21bn from an operating loss of ¥0.58bn in FY2026 Q1. Ordinary income rose to ¥2.33bn from a ¥0.73bn loss, while net income attributable to owners reached ¥1.66bn versus a ¥0.53bn loss. The operating margin recovered to 13.7% from negative 7.2%, a 2,086bp improvement. Gross margin expanded to 33.7% from 26.7%, an approximately 702bp gain, indicating substantially improved factory utilization, project mix, and/or pricing absorption. The SG&A-to-sales ratio declined to 20.0% from 33.9%, producing substantial operating leverage as revenue expanded. Semiconductor manufacturing equipment was the principal driver, with segment sales up 110.1% year on year to ¥151.33bn and segment profit improving from a ¥6.08bn loss to a ¥21.26bn profit. Medical devices remained profitable and expanded revenue, whereas laser processing equipment remained loss-making despite higher sales. Net margin was 10.2%, placing Q1 profitability above the 10% benchmark generally associated with strong earnings conversion. Ordinary income exceeded operating income by ¥0.12bn, supported by ¥0.70bn of dividend income and ¥0.51bn of interest income, partly offset by ¥0.72bn of interest expense and ¥0.87bn of foreign-exchange losses. Extraordinary items were immaterial, with a net extraordinary loss of only ¥0.01bn, so reported earnings principally reflect operating and ordinary business performance. Comprehensive income of ¥6.41bn substantially exceeded net income because of positive valuation and currency translation movements, including a ¥3.94bn valuation gain on securities; this increases equity but should not be treated as recurring operating profit. The Q1 revenue progress rate against the full-year forecast is 25.3%, broadly in line with the 25% seasonal reference point. Operating-income progress is 21.6% and net-income progress is 23.7%, modestly below the 25% reference point but not by a material level. The unchanged full-year forecast implies management continues to anticipate revenue of ¥64.0bn, operating income of ¥10.24bn, and net income of ¥7.0bn. The key issue for subsequent quarters is whether semiconductor equipment demand and production conversion can sustain the Q1 margin recovery while working-capital intensity moderates.

Profitability Analysis

Annualized DuPont ROE is 8.8%, comprising a 10.2% net profit margin, 0.556x asset turnover, and 1.54x financial leverage. The strongest component is the 10.2% net margin, which reflects the Q1 swing from loss-making operations to a 13.7% operating margin. Financial leverage is moderate rather than aggressive, so the return profile is primarily operationally driven rather than debt-driven. Asset turnover of 0.556x remains relatively modest for a manufacturing group, consistent with a sizeable asset base and long production cycle, and indicates scope for further returns improvement if sales conversion remains strong. The largest year-on-year change is the earnings-margin recovery: gross margin increased by approximately 702bp and operating margin increased by approximately 2,086bp. Revenue growth of 100.3% materially outpaced SG&A growth, with SG&A rising 18.4% to ¥3.24bn; consequently, the SG&A ratio fell 1,385bp to 20.0%. This is favorable operating leverage and was the major mechanism behind the operating-profit turnaround. The semiconductor manufacturing equipment segment is the core business, accounting for 93.5% of group revenue and 96.1% of aggregate segment profit. Its segment margin was 14.1%, compared with 19.5% in medical devices and negative 12.7% in laser processing equipment. Medical-device revenue grew 14.5% to ¥6.80bn and segment profit increased 29.3% to ¥1.32bn, demonstrating profitable but smaller-scale diversification. Laser-processing-equipment revenue increased 30.3% to ¥3.70bn, but its segment loss was ¥0.47bn, improved from a ¥0.76bn loss; recovery in this business remains incomplete. The tax burden was 0.711, equivalent to a 28.9% effective tax rate, which is within a normal range. The interest burden exceeded 1.0 because net non-operating income exceeded interest expense, while interest coverage of 30.55x indicates that current earnings comfortably service interest costs.

Growth Assessment

The Q1 result shows a pronounced demand and earnings recovery rather than a low-single-digit expansion. Group revenue increased by ¥8.10bn year on year, with semiconductor manufacturing equipment contributing ¥7.93bn of the increase. This concentration means the near-term revenue trajectory remains highly sensitive to semiconductor capital-expenditure cycles, customer acceptance timing, and equipment shipment schedules. The core segment's transition from a ¥6.08bn loss to a ¥21.26bn profit supports the view that improved volume absorption was central to the earnings turnaround. Medical devices provide a smaller, profitable earnings stream, but represented only 4.2% of Q1 sales. Laser processing equipment represented 2.3% of sales and remains a drag on aggregate profitability despite reduced losses. The full-year plan calls for 17.7% revenue growth and 48.0% operating-income growth, considerably slower than Q1's year-on-year expansion because the comparable base and quarterly demand profile become more demanding. Q1 revenue progress of 25.3% is aligned with the standard first-quarter run rate. Operating-income progress of 21.6% is 3.4 percentage points below the standard 25% run rate, and net-income progress of 23.7% is 1.3 percentage points below it; neither divergence exceeds the 10-percentage-point threshold that would indicate a material timing issue. Maintaining the full-year target requires operating margin to improve from the Q1 13.7% to the forecast-implied 16.0% for the full year, which leaves execution sensitivity to mix, utilization, and cost absorption. The absence of material impairment or goodwill movements across segments supports the view that Q1 profit was not driven by M&A accounting or asset-sale gains. Foreign-exchange losses of ¥0.87bn were material relative to the ¥2.21bn operating profit, equivalent to 3.9% of operating income, but did not alter the overall earnings recovery.

Financial Health

Liquidity is strong, with a current ratio of 227.1%, a quick ratio of 207.6%, and working capital of ¥39.89bn. Cash and deposits of ¥29.72bn cover short-term loans of ¥15.00bn by 1.98x, providing meaningful immediate refinancing capacity. Total interest-bearing debt is ¥18.60bn, comprising ¥15.00bn of short-term loans and ¥3.60bn of long-term loans. Debt-to-equity is a conservative 0.54x and debt-to-capital is 19.8%, both well below stressed-credit thresholds. Interest coverage of 30.55x further supports debt-service capacity. However, refinancing risk requires monitoring because 80.7% of interest-bearing debt is short term, well above the 40% alert threshold. This maturity structure creates reliance on continued bank funding and/or use of cash balances even though headline liquidity is sound. Short-term loans increased by ¥3.50bn, or 30.4% year on year, to ¥15.00bn, suggesting additional working-capital or operating funding needs during the expansion phase. Investment securities increased by ¥5.75bn, or 76.1%, to ¥13.30bn and now represent 11.4% of total assets. The increase, together with a ¥3.94bn valuation gain on securities recognized in OCI, increases exposure of equity and comprehensive income to market-price movements. Equity increased to ¥75.53bn from ¥70.61bn, supported primarily by comprehensive income and accumulated valuation and translation adjustments. Intangible assets represent only 2.1% of total assets, indicating no material balance-sheet concentration in acquired intangible assets. Product-warranty provisions total ¥0.33bn, equivalent to about 2.0% of Q1 revenue, a level that warrants monitoring as equipment shipments rise.

Notable B/S Changes

Investment securities: +¥5.75bn (+76.1%) to ¥13.30bn — a significant increase in marketable-investment exposure; positive securities valuation movements supported OCI but also increase equity-market sensitivity. Short-term loans: +¥3.50bn (+30.4%) to ¥15.00bn — funding increased during the growth phase and reinforces the need to monitor refinancing and working-capital conversion.

Cash Flow Quality

Receivable, inventory, and cash-conversion-cycle indicators indicate elevated working-capital intensity. Annualized receivable days are 100 days, above the 60-day warning threshold, implying slow cash collection or project-based billing and acceptance timing. Annualized inventory days are 179 days, materially above the 90-day warning threshold. The annualized cash conversion cycle is 234 days, above the 120-day warning level and indicates substantial cash tied up in the operating cycle. Work in process is ¥12.54bn and represents 59.7% of inventory, above the 40% warning threshold. The high WIP mix is consistent with a complex made-to-order capital-equipment production process, but it also raises the risk of production bottlenecks, delayed customer acceptance, cost overruns, and inventory obsolescence if semiconductor demand changes. Accounts receivable rose to ¥17.77bn from ¥16.16bn year on year, while finished goods increased to ¥6.14bn from ¥5.68bn; these movements require monitoring against future revenue recognition and customer collections. Accounts payable declined slightly to ¥5.24bn from ¥5.43bn, limiting supplier financing as the production cycle expands. The combination of higher short-term loans, elevated receivable days, high inventory days, and long cash conversion cycle is the principal cash-management concern despite strong accounting profitability.

Dividend Sustainability

The full-year dividend forecast is ¥24.00 per share and the full-year EPS forecast is ¥93.30, implying a dividend payout ratio of approximately 25.7%. This is well below the 60% sustainability benchmark and leaves a substantial earnings retention buffer. The forecast dividend requires aggregate cash dividends of roughly ¥1.80bn based on 75.0 million average shares. Forecast net income of ¥7.0bn provides earnings coverage of about 3.9x for the planned dividend. The conservative payout ratio is supportive of balance-sheet flexibility while the company manages a long manufacturing cash-conversion cycle and a predominantly short-term debt structure. No dividend revision has been announced. Dividend sustainability should therefore be assessed primarily against achievement of the full-year earnings plan and the conversion of receivables and WIP into cash.

Risk Assessment

Business risks include Semiconductor manufacturing equipment accounts for 93.5% of Q1 revenue, creating high exposure to semiconductor-capex cycles, customer investment deferrals, shipment timing, and acceptance delays., Laser processing equipment remained loss-making, with a ¥0.47bn segment loss and a negative 12.7% segment margin; continued losses could dilute group margin recovery., Annualized inventory days of 179 and WIP representing 59.7% of inventory indicate production-cycle and project-execution risk, including delays, cost overruns, and obsolescence risk., Foreign-exchange losses were ¥0.87bn in Q1, demonstrating earnings sensitivity to currency fluctuations in an export-oriented capital-equipment business., The approximately 2.0% product-warranty-provision-to-Q1-revenue ratio should be monitored as a potential indicator of service, reliability, or field-cost exposure..

Financial risks include Short-term debt accounts for 80.7% of interest-bearing debt, creating refinancing and liquidity-management risk despite cash covering short-term loans by 1.98x., Receivable days of 100, inventory days of 179, and a cash conversion cycle of 234 days can increase dependence on bank financing during periods of rapid revenue growth., Short-term loans rose ¥3.50bn year on year to ¥15.00bn, indicating increased reliance on short-term funding., Investment securities increased 76.1% to ¥13.30bn, and their valuation movements can add volatility to comprehensive income and equity..

Key concerns include Priority 1: Conversion of the exceptional Q1 semiconductor-equipment revenue surge into sustainable shipments, customer acceptance, and cash collection., Priority 2: Reduction in the 234-day annualized cash conversion cycle, particularly through normalization of WIP and receivable days., Priority 3: Refinancing discipline for the ¥15.00bn short-term loan balance and the 80.7% short-term debt ratio., Priority 4: Restoration of laser processing equipment to profitability so that it no longer offsets the core segment's margin gains., Priority 5: Preservation of gross-margin gains as semiconductor equipment demand normalizes and quarterly comparatives become more demanding..

Investment Implications

Key takeaways include Q1 marked a major turnaround: revenue rose 100.3%, operating income was ¥2.21bn versus a ¥0.58bn loss, and net income was ¥1.66bn versus a ¥0.53bn loss., Margin quality improved materially, with gross margin up approximately 702bp to 33.7% and operating margin up approximately 2,086bp to 13.7%., The semiconductor manufacturing equipment segment is the decisive earnings engine, generating ¥15.13bn of revenue and ¥2.13bn of segment profit., Balance-sheet leverage is conservative, but the debt maturity profile is short term and working-capital requirements are elevated., The ¥24 per-share full-year dividend forecast implies a modest 25.7% payout ratio based on forecast EPS..

Metrics to watch include Semiconductor manufacturing equipment revenue, segment margin, order conversion, and customer acceptance timing, Full-year operating-income progress relative to the ¥10.24bn forecast, Annualized receivable days, inventory days, WIP proportion, and cash conversion cycle, Short-term loan balance, cash-to-short-term-debt coverage, and refinancing terms, Laser processing equipment segment loss trajectory, Foreign-exchange gains or losses and investment-security valuation movements.

Regarding relative positioning, TOWA's Q1 operating margin of 13.7% is within the good 8-15% profitability range and its 10.2% net margin is strong, while annualized ROE of 8.8% is improved but remains below the 10-15% range generally associated with strong equity returns. Liquidity and leverage compare favorably with manufacturing credit benchmarks, but working-capital efficiency is weak relative to standard manufacturing thresholds, reflecting the operational characteristics and execution risks of capital-equipment production.